Literature DB >> 18257848

Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.

S Rasheed1, D M Bowley, O Aziz, P P Tekkis, A E Sadat, T Guenther, M L Boello, P J McDonald, I C Talbot, J M A Northover.   

Abstract

OBJECTIVE: The present study investigated the risk of lymph node metastasis according to the depth of tumour invasion in patients undergoing resection for rectal cancer.
METHOD: The histology of patients undergoing oncological resection with regional lymphadenectomy for rectal cancer at St Marks Hospital from 1971 to 1996 was reviewed. Of the total number of 1549 patients, 303 patients with T(1) or T(2) rectal cancers were selected. The tumour type, grade, evidence of vascular invasion, depth of submucosal invasion (classed into 'sm1-3') were evaluated as potential predictors of lymph node positivity using univariate and multi-level logistic regression analysis.
RESULTS: Tumour stage was classified as T(1) in 55 (18.2%) and T(2) in 248 (81.2%) patients. The incidence of lymph node metastasis in the T(1) group was 12.7% (7/55), compared to 19% (47/247) in the T(2) group. The node positive and negative groups were similar with regard to patient demographics, although the former contained a significantly higher number of poorly differentiated (P = 0.001) and extramural vascular invasion tumours (P = 0.002). There was no significant difference in the number of patients with sm1-3, or T(2) tumour depths within the lymph node positive and negative groups. On multivariate analysis the presence of extramural vascular invasion (odds ratio = 10.0) and tumour grade (odds ratio for poorly vs well-differentiated = 11.7) were independent predictors of lymph node metastasis.
CONCLUSION: Whilst the degree of vascular invasion and poor differentiation of rectal tumours were significant risk factors for lymph node metastasis, depth of submucosal invasion was not. This has important implications for patients with superficial early rectal cancers in whom local excision is being considered.

Entities:  

Mesh:

Year:  2008        PMID: 18257848     DOI: 10.1111/j.1463-1318.2007.01411.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  32 in total

1.  Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer.

Authors:  Pei-Rong Ding; Xin An; Yun Cao; Xiao-Jun Wu; Li-Ren Li; Gong Chen; Zhen-Hai Lu; Yu-Jing Fang; De-Sen Wan; Zhi-Zhong Pan
Journal:  J Gastrointest Surg       Date:  2010-10-05       Impact factor: 3.452

2.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

3.  Impact of tumor location on lymph node metastasis in T1 colorectal cancer.

Authors:  Erman Aytac; Emre Gorgun; Meagan M Costedio; Luca Stocchi; Feza H Remzi; Hermann Kessler
Journal:  Langenbecks Arch Surg       Date:  2016-06-06       Impact factor: 3.445

4.  The Role of Transanal Surgery in the Management of T1 Rectal Cancers.

Authors:  Imran Hassan; Paul E Wise; David A Margolin; James W Fleshman
Journal:  J Gastrointest Surg       Date:  2015-06-06       Impact factor: 3.452

Review 5.  Current concepts in rectal cancer.

Authors:  James W Fleshman; Nathan Smallwood
Journal:  Clin Colon Rectal Surg       Date:  2015-03

6.  Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer.

Authors:  Jung Wook Huh; Hyeong Rok Kim; Young Jin Kim
Journal:  J Gastrointest Surg       Date:  2010-04-30       Impact factor: 3.452

7.  Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.

Authors:  Sagar A Patel; Yu-Hui Chen; Jason L Hornick; Paul Catalano; Jonathan A Nowak; Lawrence R Zukerberg; Ronald Bleday; Paul C Shellito; Theodore S Hong; Harvey J Mamon
Journal:  Dis Colon Rectum       Date:  2014-04       Impact factor: 4.585

8.  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.

Authors:  Hale Çolakoğlu Er; Elif Peker; Ayşe Erden; İlhan Erden; Ethem Geçim; Berna Savaş
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

9.  A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer.

Authors:  Jun Yan; Fangqin Xue; Hongyuan Chen; Xiufeng Wu; Hui Zhang; Gang Chen; Jianping Lu; Lisheng Cai; Gao Xiang; Zhenwei Deng; Yu Zheng; Xiaoling Zheng; Guoxin Li
Journal:  Surg Endosc       Date:  2014-06-17       Impact factor: 4.584

10.  Role of tumor size in the pre-operative management of rectal cancer patients.

Authors:  Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Journal:  BMC Gastroenterol       Date:  2010-06-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.